Cargando...
Protective efficacy of peptides from Plasmodium vivax circumsporozoite protein
Vivax malaria is a major cause of morbidity and mortality worldwide, with several million clinical cases per year and 2.5 billion at risk of infection. A vaccine is urgently needed but the most advanced malaria vaccine, VMP001, confers only very low levels of protection against vivax malaria challen...
Gardado en:
| Publicado en: | Vaccine |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier Science
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7408485/ https://ncbi.nlm.nih.gov/pubmed/32402755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.03.063 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|